クリニカルステージIVの胃がんの転換手術後の術後の化学療法: 傾向スコアマッチ分析
Yasunori Masuike1, Takeshi Omori2, Kazuyoshi Yamamoto2
1Department of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka-Shi, Osaka-Fu, 5418567, Japan. yasunori.masuike@oici.jp.
International journal of clinical oncology
|August 27, 2025
まとめ
第4段階の胃がん手術後の術後の化学療法では,単剤療法よりも併用療法による全生存効果は示されなかった. しかし,特定の患者のサブグループは,強化された治療戦略から利益を得ることができます.
科学分野:
- 胃腸内科
- 手術腫瘍学
- 医療腫瘍学
背景:
- 4段階の胃がんの治療には 有望な戦略です
- 術後の化学療法の生存結果への影響は不明である.
- この研究では,単剤と組み合わせた化学療法による手術後の治療を比較した.
研究 の 目的:
- 第4段階の胃がん患者の生存結果に対する術後の化学療法の影響を評価する.
- 単剤対併用化学療法療法の有効性を比較する.
- 特定の化学療法アプローチから利益を得られる患者のサブグループを特定する.
主な方法:
- 第4段階の胃がんのために胃切除を受けた128人の患者の遡及研究 (2007年−2021年).
- 単剤および併用化学療法群に分類された患者.
- 生存分析に使用された傾向スコアマッチング,Kaplan-Meier曲線,Coxモデル (OSとPFS).
主要な成果:
- 単剤と組み合わせた化学療法群の間で全生存率 (OS) や無進行生存率 (PFS) で有意な差はない (p>0. 05).
- 残留腫瘍は生存率の低下を有意に予測した (p=0. 010).
- 併用療法によるPFSの潜在的な利点は,残留腫瘍のないypStage IV患者で観察された (p=0. 04).
結論:
- 術後の併用化学療法は,全体的なコホートにおける単剤治療と比較して生存率を有意に改善しなかった.
- 特定のサブグループ,特に残留腫瘍のない第4段階の患者は,加強された併用療法から利益を得ることができる.
- 第4段階の胃がんの治療戦略を精進するためにさらなる研究が必要である.
関連する概念動画
01:26Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
170
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
170
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
406
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
406
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
321
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
321
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K